Profound Medical
PROF
Profound Medical (PROF) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Lake Street | Maintained | Buy | $12.00 from $11.00 | Jan 7, 2026 |
| Lake Street | Maintained | Buy | $11.00 from $17.00 | Apr 23, 2025 |
| Stifel | Upgraded | Hold → Buy | $12.00 from $9.00 | Jul 16, 2024 |
| Alliance Global Partners | Maintained | Buy | $10.80 from $12.75 | Mar 11, 2024 |
| Stifel | Maintained | Hold | $9.00 from $11.00 | Mar 8, 2024 |
| Alliance Global Partners | Maintained | Buy | $12.75 from $14.25 | Jan 4, 2024 |
| Stifel | Initiated Coverage | Hold | $11.00 | Nov 28, 2023 |
| Raymond James | Downgraded | Strong Buy → Outperform | — | Aug 4, 2023 |
| Alliance Global Partners | Maintained | Buy | $15.75 from $13.15 | May 11, 2023 |
| TD Cowen | Maintained | Outperform | $18.00 from $14.00 | May 11, 2023 |
| Jefferies | Downgraded | Buy → Equal-Weight | $10.00 from $5.50 | Mar 21, 2023 |
Frequently asked questions
What is the latest analyst rating on PROF?
On Jan 7, 2026, Lake Street maintained Profound Medical at Buy with a price target of $12.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.